311 related articles for article (PubMed ID: 19000913)
1. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
3. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
4. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.
Zhen J; Chen N; Reith ME
Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767
[TBL] [Abstract][Full Text] [Related]
5. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
Gorentla BK; Vaughan RA
Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
[TBL] [Abstract][Full Text] [Related]
7. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.
Zhao G; Jiang ZH; Zheng XW; Zang SY; Guo LH
Pharmacol Biochem Behav; 2008 Sep; 90(3):363-71. PubMed ID: 18485464
[TBL] [Abstract][Full Text] [Related]
10. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
11. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
13. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
14. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
15. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
16. The dopamine transporter is differentially regulated after dopaminergic lesion.
Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T
Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165
[TBL] [Abstract][Full Text] [Related]
17. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
[TBL] [Abstract][Full Text] [Related]
20. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
Wang J; Michelhaugh SK; Bannon MJ
Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
